Page 45 - Remedial Andrology
P. 45

[302, 314, 315]. Atrial fibrillation  [316], hyperthyroidism  [20], vitamin D deficiency  [317, 318], hyperuricemia
            [319], depression  [320], chronic kidney disease  [313], rheumatic disease  [321] and chronic obstructive
            pulmonary disease  [322] have also been reported as risks factors. Available data do not confirm a clear
            association between ED and hypothyroidism and hyperprolactinaemia [20].
                     Further epidemiological data have also highlighted other potential risk factors associated with ED
            including sleep disorders [323], obstructive sleep apnoea [324], psoriasis [325-327], gouty arthritis [328] and
            ankylosing spondylitis [329], non-alcoholic fatty liver disease [330], other chronic liver disorders [331], chronic
            periodontitis [332], open-angle glaucoma [333], inflammatory bowel disease [334], chronic fatigue syndrome
            [335] and allergic rhinitis [336]. Insufficient data are currently available to correlate primarily organic or primarily
            psychogenic ED with SARS-CoV-2 infection associated disease (COVID-19) [337, 338].

            Erectile dysfunction is also frequently associated with other urological conditions and procedures (Table 9).
            Epidemiological studies have demonstrated consistent evidence for an association between LUTS/BPH and
            sexual dysfunction, regardless of age, other co-morbidity and lifestyle factors [339]. The Multinational Survey
            on  the  Aging  Male  study, performed  in  the  USA,  France,  Germany,  Italy,  Netherlands,  Spain,  and  the  UK,
            systematically investigated the relationship between LUTS and sexual dysfunction in > 12,000 men aged
            50-80 years. In the 83% of men who were reported to be sexually active, the overall prevalence of LUTS
            was 90%, with an overall 49% prevalence of ED and a reported complete absence of erections in 10% of
            patients. The overall prevalence of ejaculatory disorders was 46% [247]. Regardless of the technique used,
            surgery for BPH-LUTS had no significant impact on erectile function. A post-operative improvement of erectile
            function was even found depending on the degree of LUTS improvement [340, 341]. An association has been
            confirmed between ED and CP/CPPS [342], and bladder pain syndrome/interstitial cystitis (BPS/IC), mostly in
            younger men [343]. An association between ED and PE has also been demonstrated (see Section 6.2) [344]. An
            increased risk of ED is reported following transrectal ultrasound (TRUS)-guided prostate biopsy [345] and after
            open urethroplasty, especially for correction of posterior strictures [346], with recent findings emphasising the
            importance of patient-reported outcome measures (PROMs) in urethral reconstructive surgery to better report
            actual sexual function outcomes [347, 348].

            Table 9: Urological conditions associated with ED

             Urological Condition        Association with ED
             LUTS/BPH [339]              Depending on the severity of LUTS and patients’ age/population
                                         characteristics: Odds ratio (OR) of ED among men with LUTS/BPH
                                         ranges from 1.52 to 28.7 and prevalence ranges from 58% to 80%
             Surgery for BPH/LUTS (TURP,   Overall, absence of significant variations in terms of erectile function
             laser, open, laparoscopic, etc.)   scores after surgery
             [340]
             Chronic Prostatitis/Chronic Pelvic   Prevalence of ED among patients with CP/CPPS 29% [24%-33%,
             Pain Syndrome [342]         95%CI], Range: 11% - 56% among studies
             Bladder Pain Syndrome/Interstitial  OR of BPS/IC among patients with ED.
             Cystitis [343]              Overall: OR (adjusted) = 1.75 [1.12 – 2.71, 95%CI]
                                         Age > 60: OR (adjusted) = 1.07 [0.41 – 2.81, 95%CI]
                                         Age 40-59: OR (adjusted) = 1.44 [1.02 – 2.12, 95%CI]
                                         Age 18-39: OR (adjusted) = 10.40 [2.93 – 36.94, 95%CI]
             Premature Ejaculation [345]  OR of ED among patients with PE = 3.68 [2.61 – 5.68, 95%CI]
             Urethroplasty surgery for posterior  OR of ED after posterior urethroplasty = 2.51 [1.82 – 3.45, 95%CI]
             urethral strictures [346]
            CI = confidence interval; OR = odds ratio; TURP = transurethral resection of the prostate; ED = erectile
            dysfunction; BPS/IC = bladder pain syndrome/interstitial cystitis; LUTS = lower urinary tract symptoms.

            5.3      Pathophysiology
            The pathophysiology of ED may be vasculogenic, neurogenic, anatomical, hormonal, drug-induced and/or
            psychogenic (Table 10) [295]. In most cases, numerous pathophysiological pathways can co-exist and may all
            negatively impact on erectile function.

            The proposed ED etiological and pathophysiological division should not be considered prescriptive. In most
            cases, ED is associated with more than one pathophysiological factor and very often, if not always, will have a
            psychological component. Likewise, organic components can negatively affect erectile function with different
            pathophysiological effects. Therefore, Table 10 must be considered for diagnostic classifications only (along
            with associated risk factors for each subcategory).


            44                                                SEXUAL AND REPRODUCTIVE HEALTH - MARCH 2021
   40   41   42   43   44   45   46   47   48   49   50